Carmen Paradas1, Hasan O Akman2, Carolina Ionete3, Heather Lau4, Peter N Riskind3, David E Jones3, Thomas W Smith5, Michio Hirano2, Salvatore Dimauro2. 1. Department of Neurology, Columbia University Medical Center, New York, New York2Unidad de Enfermedades Neuromusculares, Servicio de Neurología, Hospital Universitario Virgen del Rocío, Instituto de Biomédicina de Sevilla, Consejo Superior de Investigación. 2. Department of Neurology, Columbia University Medical Center, New York, New York. 3. Department of Neurology, University of Massachusetts Memorial Medical Center, Worcester. 4. Rusk Institute of Rehabilitation, NYU Langone Medical Center, New York, New York. 5. Department of Pathology, University of Massachusetts Memorial Medical Center, Worcester.
Abstract
IMPORTANCE: The neuromuscular presentation of glycogen branching enzyme deficiency includes a severe infantile form and a late-onset variant known as adult polyglucosan body disease. Herein, we describe 2 patients with adult acute onset of fluctuating neurological signs and brain magnetic resonance imaging lesions simulating multiple sclerosis. A better definition of this new clinical entity is needed to facilitate diagnosis. OBJECTIVES: To describe the clinical presentation and progression of a new intermediate variant of glycogen branching enzyme deficiency and to discuss genotype-phenotype correlations. DESIGN, SETTING, AND PARTICIPANTS: Clinical, biochemical, morphological, and molecular study of 2 patients followed up for 6 years and 8 years at academic medical centers. The participants were 2 patients of non-Ashkenazi descent with adult acute onset of neurological signs initially diagnosed as multiple sclerosis. MAIN OUTCOMES AND MEASURES: Clinical course, muscle and nerve morphology, longitudinal study of brain magnetic resonance imaging, and glycogen branching enzyme activity and GBE1 molecular analysis. RESULTS: Molecular analysis showed that one patient was homozygous (c.1544G>A) and the other patient was compound heterozygous (c.1544G>A and c.1961-1962delCA) for GBE1 mutations. Residual glycogen branching enzyme activity was 16% and 30% of normal in leukocytes. Both patients manifested acute episodes of transient neurological symptoms, and neurological impairment was mild at age 45 years and 53 years. Brain magnetic resonance imaging revealed nonprogressive white matter lesions and spinocerebellar atrophy similar to typical adult polyglucosan body disease. CONCLUSIONS AND RELEVANCE: GBE1 mutations can cause an early adult-onset relapsing-remitting form of polyglucosan body disease distinct from adult polyglucosan body disease in several ways, including younger age at onset, history of infantile liver involvement, and subacute and remitting course simulating multiple sclerosis. This should orient neurologists toward the correct diagnosis.
IMPORTANCE: The neuromuscular presentation of glycogen branching enzyme deficiency includes a severe infantile form and a late-onset variant known as adult polyglucosan body disease. Herein, we describe 2 patients with adult acute onset of fluctuating neurological signs and brain magnetic resonance imaging lesions simulating multiple sclerosis. A better definition of this new clinical entity is needed to facilitate diagnosis. OBJECTIVES: To describe the clinical presentation and progression of a new intermediate variant of glycogen branching enzyme deficiency and to discuss genotype-phenotype correlations. DESIGN, SETTING, AND PARTICIPANTS: Clinical, biochemical, morphological, and molecular study of 2 patients followed up for 6 years and 8 years at academic medical centers. The participants were 2 patients of non-Ashkenazi descent with adult acute onset of neurological signs initially diagnosed as multiple sclerosis. MAIN OUTCOMES AND MEASURES: Clinical course, muscle and nerve morphology, longitudinal study of brain magnetic resonance imaging, and glycogen branching enzyme activity and GBE1 molecular analysis. RESULTS: Molecular analysis showed that one patient was homozygous (c.1544G>A) and the other patient was compound heterozygous (c.1544G>A and c.1961-1962delCA) for GBE1 mutations. Residual glycogen branching enzyme activity was 16% and 30% of normal in leukocytes. Both patients manifested acute episodes of transient neurological symptoms, and neurological impairment was mild at age 45 years and 53 years. Brain magnetic resonance imaging revealed nonprogressive white matter lesions and spinocerebellar atrophy similar to typical adult polyglucosan body disease. CONCLUSIONS AND RELEVANCE: GBE1 mutations can cause an early adult-onset relapsing-remitting form of polyglucosan body disease distinct from adult polyglucosan body disease in several ways, including younger age at onset, history of infantile liver involvement, and subacute and remitting course simulating multiple sclerosis. This should orient neurologists toward the correct diagnosis.
Authors: Fanny Mochel; Raphael Schiffmann; Marjan E Steenweg; Hasan O Akman; Mary Wallace; Frédéric Sedel; Pascal Laforêt; Richard Levy; J Michael Powers; Sophie Demeret; Thierry Maisonobe; Roseline Froissart; Bruno Barcelos Da Nobrega; Brent L Fogel; Marvin R Natowicz; Catherine Lubetzki; Alexandra Durr; Alexis Brice; Hanna Rosenmann; Varda Barash; Or Kakhlon; J Moshe Gomori; Marjo S van der Knaap; Alexander Lossos Journal: Ann Neurol Date: 2012-09 Impact factor: 10.422
Authors: C Bruno; S Servidei; S Shanske; G Karpati; S Carpenter; D McKee; R J Barohn; M Hirano; Z Rifai; S DiMauro Journal: Ann Neurol Date: 1993-01 Impact factor: 10.422
Authors: A McConkie-Rosell; C Wilson; D A Piccoli; J Boyle; T DeClue; P Kishnani; J J Shen; A Boney; B Brown; Y T Chen Journal: J Inherit Metab Dis Date: 1996 Impact factor: 4.982
Authors: Gianina Ravenscroft; Elizabeth M Thompson; Emily J Todd; Kyle S Yau; Nina Kresoje; Padma Sivadorai; Kathryn Friend; Kate Riley; Nicholas D Manton; Peter Blumbergs; Michael Fietz; Rachael M Duff; Mark R Davis; Richard J Allcock; Nigel G Laing Journal: Neuromuscul Disord Date: 2012-12-03 Impact factor: 4.296
Authors: Christopher J Klein; Christopher J Boes; John E Chapin; Christopher D Lynch; Norbert G Campeau; P James B Dyck; Peter J Dyck Journal: Muscle Nerve Date: 2004-02 Impact factor: 3.217
Authors: Stacey K H Tay; Hasan O Akman; Wendy K Chung; Michael G Pike; Francesco Muntoni; Arthur P Hays; Sara Shanske; Stephanie J Valberg; James R Mickelson; Kurenai Tanji; Salvatore DiMauro Journal: Neuromuscul Disord Date: 2004-04 Impact factor: 4.296
Authors: Miriam Fanjul-Fernández; Natasha J Brown; Peter Hickey; Peter Diakumis; Haloom Rafehi; Kiymet Bozaoglu; Cherie C Green; Audrey Rattray; Savannah Young; Dana Alhuzaimi; Hayley S Mountford; Greta Gillies; Vesna Lukic; Tanya Vick; Keri Finlay; Bradley P Coe; Evan E Eichler; Martin B Delatycki; Sarah J Wilson; Melanie Bahlo; Ingrid E Scheffer; Paul J Lockhart Journal: Hum Mutat Date: 2021-10-21 Impact factor: 4.700